• PRM75 Parallel Sets as Interactive Visualization Approach for Analyzing Markov Models

    Nov 1, 2012, 00:00

  • PCN142 Success Factors for Achieving Reimbursement for Oncology Drugs in Australia

    Nov 1, 2012, 00:00

  • PMD84 Telemonitoring After Discharge With Heart Failure - Cost-Effectiveness Modelling of Alternative Service Designs

    Nov 1, 2012, 00:00

  • PIN21 Economic Impact of Hospital-Acquired Infections in Mechanically Ventilated Patients in Intensive Care Units- Retrospective Analysis From a United States Hospital Database

    Nov 1, 2012, 00:00

  • PCV34 Health-Related Quality of Life in Chinese Patients with Stable Angina Pectoris

    Nov 1, 2012, 00:00

  • PRM30 Evaluating Readiness for Work in Patients With Schizophrenia- “The Readiness for Work Questionnaire” (WoRQ)

    Nov 1, 2012, 00:00

  • PMH1 Evaluation of Drug-Related Problems in Depressive Patients

    Nov 1, 2012, 00:00

  • PDB46 Anti-Diabetic Drugs and In-Patient Admissions Attributable to Diabetes in Portugal

    Nov 1, 2012, 00:00

  • PND12 Budget Impact Analysis of Routine Testing for Genetically Based Cardiopathies Associated With High Risk of Sudden Death in Spain- Preliminary Results

    Nov 1, 2012, 00:00

  • PND47 Assessment of Quality of Life of Australians With Young Onset Parkinson's Disease

    Nov 1, 2012, 00:00

  • PDB31 The Prevalence and Burden of Comorbid Hypertension and Obesity Among Patients With Type 2 Diabetes in Urban China

    Nov 1, 2012, 00:00

  • PHP113 The Importance of Economic Evaluations in the Assessment of Reimbursement Applicaitions

    Nov 1, 2012, 00:00

  • PHS66 Outcomes and Determinants of Caregiver Burden After First-Ever Stroke- The Erlangen Stroke Project (ESPRO)

    Nov 1, 2012, 00:00

  • CV3 Real-World Characterization of Hypertension Patients in Japan- A 1-Year Overview

    Nov 1, 2012, 00:00

  • PCV16 Use of ACE Inhibitors in Serbia in 2009 and 2010

    Nov 1, 2012, 00:00

  • PHS93 HbA1c Test Utilization Among Hospitalized Patients With Hyperglycemia

    Nov 1, 2012, 00:00

  • PUK21 Conversion From Epoetin Alfa to Darbepoetin Alfa in Hemodialysis Patients With Chronic Kidney Disease- French Monocentre Observational Study

    Nov 1, 2012, 00:00

  • PCV11 Indirect Treatment Comparison (ITC) of Novel Oral Anticoagulants for the Prevention of Thromboembolic Events in Patients With Atrial Fibrillation

    Nov 1, 2012, 00:00

  • PDB26 Evidence Requirements in Australia for Drug Reimbursement- The Survival of Cost Minimisation Analysis

    Nov 1, 2012, 00:00

  • PMH27 Cost-Effectiveness Analysis of Depression in Italy

    Nov 1, 2012, 00:00

  • PRM50 Random Number Generators in Monte Carlo Simulation

    Nov 1, 2012, 00:00

  • PCN17 Predicting the Potential Cost and Effects of Prophylactic HPV Vaccination in Males in Thailand

    Nov 1, 2012, 00:00

  • PMH19 A Rehabilitation Intervention to Help People With Severe Mental Illness Obtain and Keep a Paid Job- The Economic Evaluation

    Nov 1, 2012, 00:00

  • PGI24 Cost-Effectiveness Analysis of 48-Week Peginterferon Alpha-2a Under RGT Strategy Versus 3 Years Entecavir for the Treatment of HBeAg-Positive Chronic Hepatitis B in China

    Nov 1, 2012, 00:00

  • PCN24 Health Related Quality of Life, Direct and Indirect Cost Analysis of Stage III Colorectal Cancer Patients Receiving Different Adjuvant Chemotherapy Treatments in Taiwan- A Cost Utility Analysis

    Nov 1, 2012, 00:00

  • PMD23 Long-Term Clinical Effectiveness and Cost-Effectiveness of Catheter-Based Renal Denervation in the UK. A Model-Based Projection Based on the Symplicity HTN-2 Trial

    Nov 1, 2012, 00:00

  • PIH1 Pregnancy Outcomes After Maternal Exposure to Topical Corticosteroids- A Population-Based Cohort Study

    Nov 1, 2012, 00:00

  • PRM37 Development and Use of a Health-Related Quality of Life Tool to Help Veterinarians and Pet Owners Assess Aging Changes in Pet Dogs

    Nov 1, 2012, 00:00

  • PIH8 Medication Compliance in Erectile Dysfunction (ED) Patients Who Reported Satisfactory Restoration of Erectile Function (EF) After Oral Treatment

    Nov 1, 2012, 00:00

  • PMD53 Modeling the Health and Economic Conseqences of Self-Monitoring of Blood Glucose (SMBG) in Non-Insulin Treated Patients With Type 2 Diabetes Mellitus (T2DM) in Spain

    Nov 1, 2012, 00:00

  • PCV85 Persistence of Patients Treated Hypertensive Medication in PBM With Different Percentages of Financial Subsidy

    Nov 1, 2012, 00:00

  • PHP48 Irrational Use of Antibiotics in Balochistan. A Warning for Health Care System

    Nov 1, 2012, 00:00

  • PHP185 The Pharmacists' and Patients' Side of Policy Measures in Pharmaceutical Markets- The Effects of Changing Pharmacy Margins

    Nov 1, 2012, 00:00

  • PND9 Frequency and Impact of Relapses in German Patients With Multiple Sclerosis Based on a Longitudinal Population-Based Study

    Nov 1, 2012, 00:00

  • PCV21 Hospital Based Cost Survey of Acute Coronary Syndrome in South Korea

    Nov 1, 2012, 00:00

  • PMS16 Economic Evidence of Biologics in Rheumatoid Arthritis- A Systematic Review for Supporting Informed Decision of BNHI

    Nov 1, 2012, 00:00

  • PMH14 Real-Life Cost-Analyses of Patients With Generalized Anxiety Disorder in Denmark

    Nov 1, 2012, 00:00

  • PSY44 A Cost Effectiveness Model for the Myeloplastic Disease in Greece. Azacitidine Versus Conventional Care Regimens

    Nov 1, 2012, 00:00

  • PCV53 Economic Evaluation of a Single Pill Triple Antihypertensive Therapy With Valsartan, Amlodipine, and Hydrochlorothiazide Against Its Dual Components in Greece

    Nov 1, 2012, 00:00

  • PRM10 Use of VA Databases for Retrospective Studies in Ulcerative Colitis Outcomes Research

    Nov 1, 2012, 00:00

  • PCV11 Use of Anti-Infectives for Systemic Administration in Serbia in 2010

    Nov 1, 2012, 00:00

  • PSY25 Etanercept in Early Rheumatoid Arthritis- Economic Evaluation From the Public Payer Perspective in Brazil

    Nov 1, 2012, 00:00

  • PRM4 QALY and Productivity Loss- Empirical Evidence for “Double Counting”

    Nov 1, 2012, 00:00

  • PRM42 Managing a Systematic Literature Review Project

    Nov 1, 2012, 00:00

  • PHP5 Use of Health Services and Medicines Among Students in Serbia

    Nov 1, 2012, 00:00

  • PDB19 A Systematic Review of Recent Data Describing the Risk of Complications in Type 1 Diabetes Mellitus Patients

    Nov 1, 2012, 00:00

  • PMH4 Mirror Image Studies of Risperidone Long-Acting Injection for Chronic Schizophrenia and Schizoaffective Disorder

    Nov 1, 2012, 00:00

  • PMH13 Dementia and Alzheimer'S Disease in China- Characterization and Caregiver Burden

    Nov 1, 2012, 00:00

  • PCV28 Cost-Effectiveness of Presentation and Delayed Troponin Testing for Acute Myocardial Infarction

    Nov 1, 2012, 00:00

  • PMD76 The Effect of Insulin Pump Therapy on Health Status Among Those With Type 1 Diabetes

    Nov 1, 2012, 00:00

  • PRS13 Variation of Cost of Chronic Obstructive Lung Disease in Adults in Germany- A Systematic Review

    Nov 1, 2012, 00:00

  • PHS87 Cost of Diabetes in Insulin-Treated Patients in Bulgaria

    Nov 1, 2012, 00:00

  • PND62 Carers of People With Parkinson's Disease- Factors Related to Quality of Life

    Nov 1, 2012, 00:00

  • PMD54 Trans-Catheter Aortic Valve Implantation for the Non-Operative Management of Aortic Stenosis- A Cost-Effectiveness Analysis

    Nov 1, 2012, 00:00

  • PHS89 How Can We Measure the Impact of Clinical Pharmacy Interventions? A Retrospective Drug Cost Analysis

    Nov 1, 2012, 00:00

  • PMH33 Cost Effectiveness of Paliperidone Palmitate Versus Oral Medication in the Treatment of Schizophrenia in Austria

    Nov 1, 2012, 00:00

  • PHP23 Does Combination Pharmacological Intervention for Smoking Cessation Prevent Post-Cessation Weight Gain?

    Nov 1, 2012, 00:00

  • PSY47 The Relationship Between Pain Severity and Health Utilities- Informing Clinical Trial Design to Substantiate Value

    Nov 1, 2012, 00:00

  • PRM141 Combining an Ordered Logit Model With Individual Patient-Level Data to Robustly Estimate Within-Category Visual Acuity Starting Distributions- An Innovative Modeling Approach in the Case of Vitreomacular Traction

    Nov 1, 2012, 00:00

  • PRM137 Reminders Help Improving Completion Rate of Home-Administered Lifestyle Questionnaires

    Nov 1, 2012, 00:00

  • PRM69 Network Meta-Analysis of Interventions for Overactive Bladder and Detrusor Instability – a Hierarchical Modelling Approach

    Nov 1, 2012, 00:00

  • PCV71 Economic Evaluation of Lipid Lowering Therapy in the Secondary Prevention Setting in the Philippines

    Nov 1, 2012, 00:00

  • PCV31 Cost-Effectiveness of Apixaban Versus Enoxaparin for the Prevention of Postsurgical Venous Thromboembolism in Korea

    Nov 1, 2012, 00:00

  • PSY41 Symptoms and Impacts Associated With Anaemia of Chronic Kidney Disease (CKD)

    Nov 1, 2012, 00:00

  • VA3 How Agent-Based Models Reveal the Dynamic of Epidemics – a Case Study on Influenza

    Nov 1, 2012, 00:00

  • PRM29 Preliminary Validation of the Work Productivity Activity Impairment (WPAI) in Caregivers of Children Hospitalized for Respiratory Illness (WPAI- CHRI) in Germany and Canada

    Nov 1, 2012, 00:00

  • PCV37 VIP Study- Incremental Cost During Hospitalization After Total Knee and Hip Arthroplasty in Brazilian Health Care Services

    Nov 1, 2012, 00:00

  • PHP3 Integration of Evidence on Patient Preferences in Health Care Decision Making- Current State of Play

    Nov 1, 2012, 00:00

  • PND11 Lacosamide for the Treatment of Partial Onset Seizures With or Without Secondary Generalisation- Cost-Effectiveness Analysis on Treating Patients With Lacosamide in Combination With a Non-Sodium Anti-Epileptic Medication

    Nov 1, 2012, 00:00

  • PCV27 Pharmacoeconomic Evaluation of Neuroprotective Therapy of Patients With Acute Ischemic Stroke in Ukraine

    Nov 1, 2012, 00:00

  • PRM48 The Half-Cycle “Correction”- How Much of a Correction is it?

    Nov 1, 2012, 00:00

  • PRM115 Modelling the Relationship Between Disease Severity and Utility in Multiple Sclerosis

    Nov 1, 2012, 00:00

  • PIN15 Prevalence of Hospital-Acquired Infections in Intensive Care Units and Attributable Mortality- Different Sources of Data in United-States

    Nov 1, 2012, 00:00

  • PND48 Health State Values in Alzheimer'S Disease – Baseline Results From a Large Prospective Observational Study in Three European Countries (GERAS)

    Nov 1, 2012, 00:00

  • PMS61 Health-Related Quality of Life After Vertebral Fracture- Differences Between the EQ-5D and Time-Trade-Off Instruments

    Nov 1, 2012, 00:00

  • PCV48 Systematic Review of Cost-Effectiveness Models for Pharmacologic Stroke Prevention in Atrial Fibrillation

    Nov 1, 2012, 00:00

  • PCV114 Generic Substitution and Prescription in Slovak Health Conditions

    Nov 1, 2012, 00:00

  • PHP179 Evaluation of Prescribing Practices of Clinicians in Government Teaching Hospital in Pakistan

    Nov 1, 2012, 00:00

  • PHP81 Factors Influencing Interprofessional Collaboration- A Literature Review from 2004-2011

    Nov 1, 2012, 00:00

  • PMD39 The Economic Burden of Atrial Fibrillation among Elderly Populations in Selected Developed Countries

    Nov 1, 2012, 00:00

  • PIN6 Japanese Encephalitis in Asia- Clinical Burden and Cost-Effectiveness of Vaccination Program

    Nov 1, 2012, 00:00

  • Table of Contents

    Nov 1, 2012, 00:00

  • PDB7 Network Meta-Analysis of Fixed Dose Combination Therapies for the First-Line Treatment of Type 2 Diabetes Mellitus

    Nov 1, 2012, 00:00

  • PRM35 Relative Efficiency of the SF-8, SF-12, and SF-36 in the General Population

    Nov 1, 2012, 00:00

  • PHP19 Comprehensive Value Estimation of Adalimumab-Based Treatments- Covet Study

    Nov 1, 2012, 00:00

  • PCN144 Access to Cancer Interventions Across the UK- To What Extent Does SMC Advice Agree with Nice'S End-of-Life Therapies?

    Nov 1, 2012, 00:00

  • PCV100 Comparison of Health-Related Work Impairment in Russian Patients with US and 5EU

    Nov 1, 2012, 00:00

  • PRM80 Proportional Hazards Assumption and Its Impact on Results of Cost-Effectiveness Analysis

    Nov 1, 2012, 00:00

  • PMD9 A Comparative Assessment of Cost Implications of Novel Drug Versus Novel Device-Based Treatments for Stroke Prevention in Atrial Fibrillation

    Nov 1, 2012, 00:00

  • PCN151 HTAs for the Deadliest Diseases- What Can We Learn from Multi-National Comparisons of Oncology and Cardiology Health Technology Assessments?

    Nov 1, 2012, 00:00

  • PHP68 The Effect of Resetting the Clock in Health Care

    Nov 1, 2012, 00:00

  • PHS38 Cost-Effectiveness Analysis of a Helpline for Suicide Prevention

    Nov 1, 2012, 00:00

  • PMS18 Impact of Etanercept-Methotrexate Therapy on Patient-Reported Outcomes in Moderately Active Rheumatoid Arthritis (RA) Patients of Europe, Latin America, and Asia

    Nov 1, 2012, 00:00

  • PSU20 A Cost-Effectiveness Analysis of Minimally Invasive Versus Open Surgery Techniques for Lumbar Spine Fusion

    Nov 1, 2012, 00:00

  • PHP31 The Value of Investigational Medical Products

    Nov 1, 2012, 00:00

  • RU3 Some Issues With the Icer in Technology Assessments of Screening Interventions for Rare Conditions

    Nov 1, 2012, 00:00

  • PHP141 Effects of Changing Health Policy on Pharmacoeconomics and Health Outcome Studies in Turkey

    Nov 1, 2012, 00:00

  • PHP31 Knowledge and Practice of Disposal of Date Expired and Unused Drugs

    Nov 1, 2012, 00:00

  • PIH2 Duloxetine Use in Pregnancy- A Prospective, Comparative Study of Exposed Infants

    Nov 1, 2012, 00:00

  • PCV18 Cardiovascular Risk Assessment Using Framingham Risk Equation in Newly Diagnosed Type 2 Diabetic Indian Patients

    Nov 1, 2012, 00:00

  • RE4 Beyond the Evidence - The Influence of Decision Processes on Outcomes in Coverage Determination of Health Technologies

    Nov 1, 2012, 00:00

  • PHP21 How Will the New NHS Decentralised Reforms Impact on Access to Medicines in England?

    Nov 1, 2012, 00:00

  • PUK2 Issues in the Systematic Review of Drugs for Rare Diseases- A Case Study of Eculizumab for aHUS

    Nov 1, 2012, 00:00

  • PCV6 Comparative Effectiveness of Different Drug-Eluting Coronary Stents - A Systematic Review of Taiwan Studies

    Nov 1, 2012, 00:00

  • PMS17 Burden of Ankylosing Spondylitis in Urban China

    Nov 1, 2012, 00:00

  • PND71 Predictors of Treatment Class Choice in Parkinson's Disease

    Nov 1, 2012, 00:00

  • PHS13 Costs Analysis of a Mobile Phone Telemonitoring System for Glycaemic Control in Patients With Diabetes Mellitus (DM) in Spain- Preliminary Results

    Nov 1, 2012, 00:00

  • PRM107 Nonprobability Versus Probability-Based Patient Sampling- Understanding Response Variation and Implications

    Nov 1, 2012, 00:00

  • PHP90 The Risk of Withdrawal from Labor Force in Patients with Bipolar Disorders in Taiwan

    Nov 1, 2012, 00:00

  • PDB17 Comparison of Clinical and Economic Outcomes Associated With Dpp4 Inhibitors (DPP4I) Versus Sulfonylurea (SU) in Combination with Metformin (MET) or Pioglitazone (PIO) for the Treatment of Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2012, 00:00

  • PHP106 Impact of Payer Perceptions of Pharma Companies on Access Decisions - an Analysis of Unprompted Expressions in Payer Interviews

    Nov 1, 2012, 00:00

  • PDB33 Physician'S and Patient'S Perceptions and Beliefs Regarding Insulin Initiation and Use in Patients With Type 2 Diabetes (T2DM) in China

    Nov 1, 2012, 00:00

  • PSS28 Long-Term Improvement in Patient-Reported Outcomes After Transition From Methotrexate to Ustekinumab in Moderate to Severe Psoriasis- Transit Week 52 Results

    Nov 1, 2012, 00:00

  • PMS34 Cost-Effectiveness Analysis of Bemiparin as Prophylaxis for Venous Thromboembolism in Total Knee Replacement Surgery in Mexico

    Nov 1, 2012, 00:00

  • PHP36 Analysis of the Reimbursement Decisions of the National Health Insurance Fund of Hungary (2007-2011)

    Nov 1, 2012, 00:00

  • PCN41 Cost-Effectiveness Analysis of Immunonutrition for Upper Gastrointestinal Cancer Patients Undergoing Surgery in British Hospitals

    Nov 1, 2012, 00:00

  • PHS21 Out-of-Pocket Financial Burden in Atrial Fibrillation and Potential Impact on Care- Comparison Across Five European Countries Using the European Patient Survey in Atrial Fibrillation (EUPS-AF)

    Nov 1, 2012, 00:00

  • PRM1 Kaplan-Meier Survival Curves- A Potential Source of Data for Systematic Reviews

    Nov 1, 2012, 00:00

  • PMD14 Potential Impact of Regional Cerebral Oxygen Saturation Monitoring During Coronary Artery Bypass Surgery on the Patient Reimbursement Budget in Turkey

    Nov 1, 2012, 00:00

  • PRM113 Development of a Generic Spanish Version of the Modified Myelofibrosis Symptom Assessment Form (MFSAF) Diary

    Nov 1, 2012, 00:00

  • PRM84 Using Proportional Hazard Models to Predict Price Changes of Oncology Drugs in the United States

    Nov 1, 2012, 00:00

  • PSS29 Assessing the Clinical Meaningfulness of 1-Line Average Change in Visual Acuity Among Patients With Diabetic Macular Edema- Evidence From Health-Related Quality of Life Changes

    Nov 1, 2012, 00:00

  • PRM31 Assessment of Adoption of United States Prescribing Guidelines for Dabigatran in a Real World Population

    Nov 1, 2012, 00:00

  • PHS18 Economic Burden of Atopic Dermatitis from a United States Payer Perspective

    Nov 1, 2012, 00:00

  • PCV8 Evaluation of Efficacy and Safety of Antihypertensive Drugs on the Reimbursement List for Delisting Policy in Korea

    Nov 1, 2012, 00:00

  • PND3 The Population-Based Impact of MS in Asia

    Nov 1, 2012, 00:00

  • Copyright/Subscription

    Nov 1, 2012, 00:00

  • PHP89 Perception Analysis of Pharmaceutical Care Practices Among General Physicians from Part of South India

    Nov 1, 2012, 00:00

  • PSU9 Budget Impact of Autograft Harvest, Bone Graft Supplements and Orthobiologic Bone Graft Substitute in Foot and Ankle Fusion Procedures

    Nov 1, 2012, 00:00

  • PCV92 Comparison of the Psychometric Properties of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) and the SF-36 in Patients with Pulmonary Hypertension

    Nov 1, 2012, 00:00

  • PSS14 Cost-Effectiveness of Biologic Therapies for the Treatment of Moderate to Severe Psoriasis in Germany

    Nov 1, 2012, 00:00

  • PIN18 Rates of Influenza Complications by High Risk Group

    Nov 1, 2012, 00:00

  • PIH11 Cost of Unintended Pregnancy in the UK- A Role for Increased Use of Long-Acting Reversible Contraceptive Methods

    Nov 1, 2012, 00:00

  • PRM93 Infantile Hemangioma on Families,Creation of a Specific Burden Questionnaire

    Nov 1, 2012, 00:00

  • PCN55 The Cost of Rare Diseases- The Example of Chronic Lymphocytic Leukemia

    Nov 1, 2012, 00:00

  • PMD48 Structured SMBG in Iranian People With Type 2 Diabetes- A Cost Consequence Analysis

    Nov 1, 2012, 00:00

  • PHP171 HTA Principles Inclusion in New European Union Member States

    Nov 1, 2012, 00:00

  • PCV25 Hospitalization Costs of Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention- Comparison Between Clopidogrel and Prasugrel Patients in a United States Hospital Database

    Nov 1, 2012, 00:00

  • PMD17 Use of Sterrad® Sterilizers Results in Cost-Savings Compared to Steam Sterilization in an Italian Hospital Setting

    Nov 1, 2012, 00:00

  • PSS4 The Cost-Effectiveness of Travoprost Preserved With Polyquad® in Newly Treated Open-Angle Glaucoma Patients in 7 Asian Countries

    Nov 1, 2012, 00:00

  • PRS16 Socioeconomic Burden of COPD in Ukraine- 2012-2020 Perspective Modeling

    Nov 1, 2012, 00:00

  • PIN51 Health Economic Evaluation of the Vaccination Against Herpes Zoster and Postherpetic Neuralgia in Germany

    Nov 1, 2012, 00:00

  • PCV33 Economic Burden of Cardiovascular Diseases in Russian Federation

    Nov 1, 2012, 00:00

  • PRM2 Assessing Relative Clinical Value Within Three Metastatic Diseases

    Nov 1, 2012, 00:00

  • PMD15 Budget Impact Analysis of Vascular Closure Devices (VCDs) in Italy and Spain

    Nov 1, 2012, 00:00

  • PRM155 A Pragmatic Randomized Clinical Trials – Design and Quality Assessment of the Source of Effectiveness Data

    Nov 1, 2012, 00:00

  • PCN37 A Pharmacoeconomic Analysis of the Implementation of Gefitinib in the Treatment of Metastasized Non-Small Cell Lung Cancer (NSCLC) With Proven EGFR-TK Mutations

    Nov 1, 2012, 00:00

  • PIH37 Trends of Quality of Life in South Korean Adults During 2007-2010

    Nov 1, 2012, 00:00

  • PHP47 Impact of Economic and Policy Factors on China'S Health Care Expenditure

    Nov 1, 2012, 00:00

  • PMS7 Biologic Disease-Modifying Anti-Rheumatic Drugs and the Risk of Non-Vertebral Osteoporotic Fractures in Patients With Rheumatoid Arthritis Aged 50 Years and Over

    Nov 1, 2012, 00:00

  • PHP29 Considerable Differences in the Utilization of Antidepressants Between Serbia and Denmark

    Nov 1, 2012, 00:00

  • PRM119 Mapping Between Composite Measures in Psoriatic Arthritis and the SF-6D- Analysis From the Grace Dataset

    Nov 1, 2012, 00:00

  • PCN61 Melody Brazil – Resource Use and Associated Costs With Metastatic Melanoma in Brazilian Health Care System

    Nov 1, 2012, 00:00

  • PRM15 Assessing the Broader Impact of Vaccinations- A Government Perspective Quantitative Analytic Framework Applied to Vaccination

    Nov 1, 2012, 00:00

  • PMS27 The Method for Reversing Anticoagulation Affects Treatment Costs and May Decrease Mortality Among Hip Fracture Patients Using Warfarin

    Nov 1, 2012, 00:00

  • PND4 Capsaicin 8% Patch Monotherapy for Treatment of Post-Herpetic Neuralgia- Integrated Analysis of Phase III Studies

    Nov 1, 2012, 00:00

  • PRM135 Validity, Reliability and Responsiveness of the Spanish Minnesota Living With Heart Failure Questionnaire

    Nov 1, 2012, 00:00

  • PRM78 Mapping of the National Eye Institute 25-Item Visual Functioning Questionnaire (VFQ-25) to EQ-5D Utility Scores

    Nov 1, 2012, 00:00

  • PCV89 Experience Sampling to Obtain Health State Valuations

    Nov 1, 2012, 00:00

  • PHS75 Analysis of Costs and Reimbursement of Hospital Treatment of Venous Thromboembolism in Poland

    Nov 1, 2012, 00:00

  • PCN33 Health Related Quality of Life in Post-Operative Breast Cancer Patients

    Nov 1, 2012, 00:00

  • PMS4 Inhibition of Carrageenan-Induced Edema by Stachys Fruticulosa Extract in Rats

    Nov 1, 2012, 00:00

  • PDB78 Determinants of Treatment Changes of Oral Anti/Diabetic Drugs in the UK

    Nov 1, 2012, 00:00

  • PHP48 Health Financing for Prisoners with HIV- Lesson Learned from Indonesia

    Nov 1, 2012, 00:00

  • PRM73 The Use of Cumulative Hazard Plots to Inform Resource Allocation and Research Decisions in Health Care

    Nov 1, 2012, 00:00

  • PSS5 New Formulation of Travoprost Reduces Dry Eye Occurrence and Costs in Glaucoma Patients- Model-Based Results for Hong Kong

    Nov 1, 2012, 00:00

  • PHS4 Epidemiology and Control of Tuberculosis in Ooty

    Nov 1, 2012, 00:00

  • PIH21 Health Economic Evidence in Support of a Low-Dose Contraceptive Levonorgestrel Intrauterine System (LNG-IUS 12)

    Nov 1, 2012, 00:00

  • PIN8 Assessment of Tuberculosis Burden in China Using a Dynamic Disease Simulation Model

    Nov 1, 2012, 00:00

  • PCV67 Mind the Gap! Geographic Transferability of Economic Evaluation in Health

    Nov 1, 2012, 00:00

  • PDB54 Systematic Literature Review of Utility Values Associated With Type 2 Diabetes-Related Complications

    Nov 1, 2012, 00:00

  • PDB27 The Relationship Between the Presence of Metabolic Complications and Cost Components of Type 2 Diabetes Mellitus Patients in Turkey

    Nov 1, 2012, 00:00

  • PUK23 Burden of Chronic Kidney Disease in German Diabetes Patients, a Systematic Literature Review and Data Gap Analysis

    Nov 1, 2012, 00:00

  • PHP138 Impact of Value Based Pricing on Future of Patient Access Schemes in the UK

    Nov 1, 2012, 00:00

  • PIN58 Cost Per Sustained Virological Response of Telaprevir and Boceprevir in the Treatment of Genotype 1 Hepatitis C Patients According to the Previous Treatment Response and the Metavir Groups in Brazil

    Nov 1, 2012, 00:00

  • PHP186 Trends in the Use of Health Economic Data to Inform Global Market Access Decisions- Preliminary Results from an Online Survey

    Nov 1, 2012, 00:00

  • PHP2 Economic Cost Savings of Technological Improvement for Lower-Level Hospitals- A Pilot Study in China

    Nov 1, 2012, 00:00

  • PRM108 Reliability, Validity, and Ability to Detect Change of the Fact-an for Use in Patients With Anaemia Associated With Chronic Kidney Disease

    Nov 1, 2012, 00:00

  • PRS22 Cost-Effectiveness of Beclomethasone/Formoterol Versus Fluticasone/Salmeterol in the Treatment of Patient With Moderate to Severe Asthma in Spain

    Nov 1, 2012, 00:00

  • PND9 Burden of Multiple Sclerosis (MS) in China

    Nov 1, 2012, 00:00

  • PHP7 Health Care Decision Making in Mainland China, Korea, and Taiwan- The Road Ahead?

    Nov 1, 2012, 00:00

  • PHP58 Direct Cost of Adverse Drug Reaction Treatment in Hospitalized Patients in Nakhon Pathom Hospital, Thailand

    Nov 1, 2012, 00:00

  • PCN90 Cost Effectiveness Analysis of Bendamustine as First Line Treatment for Chronic Lymphocytic Leukaemia in the Netherlands

    Nov 1, 2012, 00:00

  • PRM45 Utility Estimation for Visual Acuity Health States- An Original and Pragmatic Approach to Transpose Published Evidence Into a More Flexible Estimation

    Nov 1, 2012, 00:00

  • PHS46 Cost-Effectiveness of a Secondary Prevention Program in Patients With Myocardial Infarction- Results from a Randomised Controlled Trial (Proactive Heart)

    Nov 1, 2012, 00:00

  • PMD12 A Budget Impact Model to Investigate Potential Cost Savings Associated With the Use of Safety-Engineered Sharp Devices in Belgium

    Nov 1, 2012, 00:00

  • PCN102 The Cost of Absenteeism and Short-Term Disability Associated With Colorectal Cancer- A Case-Control Study

    Nov 1, 2012, 00:00

  • PSY10 An Indirect Comparison of Icatibant and Four Other Therapies for the Symptomatic Treatment of Acute Attacks of Hereditary Angioedema Types I and II

    Nov 1, 2012, 00:00

  • QL4 The Impact of Disease Information on General Public Preferences for Health States- Comparing Labeling, Disease-Specific, and Adaptation Information

    Nov 1, 2012, 00:00

  • PHP155 A Comparative Study of the Multiple Technology Assessment Process in the UK and Australia

    Nov 1, 2012, 00:00

  • DB2 Economic Consequences of Severe Hypoglycaemia – Preliminary Findings from Five Central European Countries

    Nov 1, 2012, 00:00

  • PSU1 3-Year Real-World Outcomes With the Swedish Adjustable Gastric Bandtm in France

    Nov 1, 2012, 00:00

  • PMS26 Assessment of the Burden of Rheumatoid Arthritis in Fran Analysis of a National Representative Claim Database

    Nov 1, 2012, 00:00

  • PRM13 Methods for Estimating Survival Benefits in the Presence of Treatment Crossover- A Simulation Study

    Nov 1, 2012, 00:00

  • PHS16 Relationship of Polymedication in Controlling Blood Pressure- Compliance, Persistence, Costs and Incidence of New Cardiovascular Events

    Nov 1, 2012, 00:00

  • PCN29 HRQOL During Adjuvant Chemotherapy With Capecitabine in Patients After Surgery for Colon Cancer- Additional Study of JFMC37-0801

    Nov 1, 2012, 00:00

  • PSY2 Preliminary Validation of Collect Scale- A Co-Morbidity Assessment Tool for Patients With Chronic Lymphocytic Leukaemia

    Nov 1, 2012, 00:00

  • PHS90 How Do Pharmacists Advise Diabetes Patient Self-Management During the Holy Month of Ramadan?

    Nov 1, 2012, 00:00

  • DU2 Contribution of Prolonged-Release Melatonin and Anti-Benzodiazepine Campaigns to the Reduction of Benzodiazepine and Z-Drug Consumption in Nine European Countries

    Nov 1, 2012, 00:00

  • PMD31 Impact of Using a Vessel Sealer System and the Harmonic Scalpel in Hospital Outcomes and Cost of Thyroidectomy Procedures

    Nov 1, 2012, 00:00

  • PUK18 Cost-Effectiveness of Angiotensin-Converting Enzyme Inhibitors in Non-Diabetic Advanced Renal Disease – A Dutch Perspective

    Nov 1, 2012, 00:00

  • PHP192 Recent Global Insights Into Risk Sharing Agreements- A Comparative Analysis

    Nov 1, 2012, 00:00

  • VA1 A European-Wide Study on the Role of Streptococcus Pneumoniae in Community-Acquired Pneumonia among Adults- A Meta-Analysis

    Nov 1, 2012, 00:00

  • PHP90 Japanese Pricing Reform in April 2012- Toward Cost Containment

    Nov 1, 2012, 00:00

  • PHS67 Rasch Model Validation of a Peer Relations Scale for People Treated for Psychoactive Substance Use Disorder

    Nov 1, 2012, 00:00

  • PSU26 Health-Related Quality of Life in Familial Amyloidotic Polyneuropathy Before and After Liver Transplantation- A Systematic Literature Review

    Nov 1, 2012, 00:00

  • PMD4 Cardiovascular Risk Prevalence in High Risk Primary Care Patients Not Treated With Lipid-Lowering Treatment in France, Results of an Online Study

    Nov 1, 2012, 00:00

  • PCV4 The Optimal Interval of Framingham Risk Score to Detect Cardiovasular Disease in Healthy Adults- A Large Cohort Study in Japan

    Nov 1, 2012, 00:00

  • PRM43 A Systematic Review on the Application of Cardiovascular Risk Prediction Models in Pharmacoeconomics, With a Focus on Primary Prevention

    Nov 1, 2012, 00:00

  • ISPOR 5th Asia-Pacific Conference Disclosure Information for Research Presentations

    Nov 1, 2012, 00:00

  • PHP52 The Cardiovascular Drug Utilisation in Croatia in the Period 2007-2010, Trends and Perspectives

    Nov 1, 2012, 00:00

  • PSY6 Economic Efficiency of Ferric Carboxymaltose to Treat or Prevent Iron Deficiency Anemia- Value to the Portuguese Hospitals

    Nov 1, 2012, 00:00

  • PCN149 Uncertainty Regarding NICE's End-of-Life Small Patient Population Criteria

    Nov 1, 2012, 00:00

  • PMH11 The Cost-Effectiveness of Risperidone Long-Acting Injection in Schizophrenia Treatment- A Systematic Review

    Nov 1, 2012, 00:00

  • CN1 Statins and the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Virus Infection

    Nov 1, 2012, 00:00

  • PCV23 Economic Evaluation of Ezetimibe Co-Administration for High Coronary Heart Disease (CHD) Risk Patients Not at Goal With Current Statin Therapy in Thailand

    Nov 1, 2012, 00:00

  • PRM139 Including Patients in Multiple Groups and Multiple Times in the Same Group in Longitudinal Observational Research- A Cystic Fibrosis Example

    Nov 1, 2012, 00:00

  • PRS17 Availability, Affordability and Price of Asthma Medicines in Tehran; Iran

    Nov 1, 2012, 00:00

  • PGI31 Impact of Treatment Response on Health Utilities and Work Productivity Among Patients With Irritable Bowel Syndrome With Constipation- Pooled Results From Phase III Clinical Trials

    Nov 1, 2012, 00:00

  • PGI28 Gastroesophageal Reflux Disease- Impact on Work Productivity and Daily Life Activities of Daytime Workers. A French Cross Sectional Study (ACTA)

    Nov 1, 2012, 00:00

  • PCN28 A Feasibility Study on Applying Preference-Based Quality-of-Life Measures in Chronic Myeloid Leukemia Outpatients Treated With Imatinab in Taiwan

    Nov 1, 2012, 00:00

  • PRS11 The Short-Term Economic Impact of Three Childhood Preventive Health Programs in Israel

    Nov 1, 2012, 00:00

  • PGI21 Cost Effectiveness of the Combination of Boceprevir Plus Peginterferon Alpha and Ribavirin Versus Telaprevir Plus Peginterferon Alfa and Ribavirin in the Retreatment of Patients With Chronic Hepatitis C Virus Genotype I Infection

    Nov 1, 2012, 00:00

  • PMD16 The Budgetary Impact of Using the Simtomax® Testing Kit for the Diagnosis of Coeliac Disease in the UK

    Nov 1, 2012, 00:00

  • PHP174 Physical Activity Matters- The Associations Between Body Mass Index, Physical Activity and Health-Realted Quality-of-Life Trajectories Over 10 Years

    Nov 1, 2012, 00:00

  • PCN30 Use of Mind Body Complementary Therapies (MBCTs) Among Malaysian Oncology Patients

    Nov 1, 2012, 00:00

  • PHP127 Reimbursement of Orphan Drugs- What is the Difference?

    Nov 1, 2012, 00:00

  • PCN115 Quality of Life in Lung Cancer Patients During Adjuvant or Palliative Chemotherapy

    Nov 1, 2012, 00:00

  • PMS71 Utilization of Duloxetine and Celecoxib in Osteoarthritis Patients

    Nov 1, 2012, 00:00

  • PMS77 Real-World Comparison of Health Care Utilization Between Duloxetine Initiators and Pregabalin Initiators Among Fibromyalgia Patients

    Nov 1, 2012, 00:00

  • PHS11 Relationship Between Physical Function and Muscle Strength in the United States Elderly Population

    Nov 1, 2012, 00:00

  • PCV64 Cost-Effectiveness of Ticagrelor in the Management of Acute Coronary Syndromes in Belgium

    Nov 1, 2012, 00:00

  • DB1 Assessing the Relationship Between the Effect of Glycemic Control and Avoided Symptomatic Hypoglycemia on Quality of Life in the Management of Type 2 Diabetes

    Nov 1, 2012, 00:00

  • PRS31 Cost-Effectiveness of an Intensive Intervention Program in the Control of Allergic Rhinitis Due to Ragweed Pollen in Quebec, Canada

    Nov 1, 2012, 00:00

  • PHS65 Mapping the Disease-Specific FACT-P to the Preference-Based EQ-5D in Castration-Resistant Prostate Cancer

    Nov 1, 2012, 00:00

  • PMS6 Anti-Tumour Necrosis Factor (TNF) Drugs for the Treatment of Psoriatic Arthritis (PsA)

    Nov 1, 2012, 00:00

  • PHP81 Microeconomic Surplus or Convenience in Health Care- Applied Economic Theory in Health Care in Three European Countries

    Nov 1, 2012, 00:00

  • PHP38 Persistent Racial and Ethnic Disparities in Health Care Utilization – Evidence from National Health Interview Survey

    Nov 1, 2012, 00:00

  • PCV3 One-Year Outcomes and Prognostic Factors in Severe Sepsis and Septic Shock Survivors

    Nov 1, 2012, 00:00

  • PMD34 Economic Comparative Evaluation of a Surgical Film Dressing in the Management of Post-Operative Surgical Wounds. An Inexepensive and Simple Solution to a Costly Problem

    Nov 1, 2012, 00:00

  • PCN155 Is Sale of Tobacco and Smoking Prevalence Predictors of Future Lung Cancer Incidence?

    Nov 1, 2012, 00:00

  • PCN77 Cost Effectiveness Analysis in the Veneto Region of Nab-Paclitaxel Monotherapy II Line Versus Conventional Paclitaxel in Patients With Breast Cancer and for Whom Anthracyclines are Not Indicated

    Nov 1, 2012, 00:00

  • PHP79 Review of Research Guidelines for Economic Evaluation Proposed by the Government and Government-Funded Research Groups in Japan

    Nov 1, 2012, 00:00

  • PHP1 Incorporating the Patient's Voice Into the Assessment of Medical Devices- A Comparison of the United States and Europe

    Nov 1, 2012, 00:00

  • PSY8 Number Needed to Treat (NNT) and Cost Estimation to Achieve a Major Molecular Response (MMR) in Newly Diagnosed Chronic Myeloid Leukemia Patients in Greece

    Nov 1, 2012, 00:00

  • PCV5 Comparison of Atrial Measurements and Estimations of Transmitral Regurgitation Using Three-Dimensional and Conventional Echocardiography in Dogs

    Nov 1, 2012, 00:00

  • PHP194 Why Do Patients Engage in Medical Tourism?

    Nov 1, 2012, 00:00

  • PRM130 Translatability of Response Sets Used in Patient Reported Outcomes and Best Practices for Development

    Nov 1, 2012, 00:00

  • ME3 Censor Adjusted Net Monetary Benefit of Anti-HCV Therapy in the Variety of Real-World Treatment Setting

    Nov 1, 2012, 00:00

  • CV1 Statin Prescription in Australia- A Comparison of Differences in Prescribed Doses and Potential Impact on Health Outcomes

    Nov 1, 2012, 00:00

  • PCV10 Analysis of Consumption of ACE Inhibitors Funded by Republic Fund of Health Insurance of the Serbia in 2009

    Nov 1, 2012, 00:00

  • PMS15 Determinants of Total Health Care Costs Associated With Ankylosing Spondylitis Prevalent Cases in Turkey

    Nov 1, 2012, 00:00

  • PMD24 Economical Aspects of the Reimbursement of Extracorporeal Photopheresis (ECP) in Treatment of Patients With Graft-Versus-Host Disease (GvHD) After Allogeneic Hematopoietic Cell Transplantation (HCT) Who are Refractory to Steroid Treat ...

    Nov 1, 2012, 00:00

  • NI4 Analysis of Stakeholders Involved in HTA Decision Making Process in the UK

    Nov 1, 2012, 00:00

  • PIN73 Direct Medical Costs and Health Care Resource Use Associated With Hepatis C Infection in Portugal

    Nov 1, 2012, 00:00

  • PRM38 Measurement Properties of the Spanish Version of the Pediatric Promis Fatigue Item Bank

    Nov 1, 2012, 00:00

  • PRM100 Converting EORTC QOl-C30 Scores to Utility Values- Is it Plausible?

    Nov 1, 2012, 00:00

  • PCV69 Economic Evaluation of Thrombo Incode, a Genetic Platform for the Assessment of Venous Thromboembolism (VTE) Risk in Patients With a Pattern of VTE or a Condition That Suggests a Hereditary Component

    Nov 1, 2012, 00:00

  • CA3 Use of Health Care Administrative Databases to Estimate the Burden of Breast Cancer

    Nov 1, 2012, 00:00

  • PDB48 Health Care Resources Utilization and Costs Associated With the Management of Patients With Acromegaly- An Analysis Based on the Ramq Database

    Nov 1, 2012, 00:00

  • PHP95 Factors Associated with Physician Participation in a National Continuing Medical Education Program

    Nov 1, 2012, 00:00

  • PMS41 Cost-Effectiveness of Denosumab in Preventing Osteoporotic Fractures in Postmenopausal Women from the Private Health Care Setting Perspective in Brazil

    Nov 1, 2012, 00:00

  • PHP125 An Early Assessment of the German Federal Joint Commission Resolutions of Additional Clinical Benefit

    Nov 1, 2012, 00:00

  • MO4 Treatment Discontinuation in Economic Modelling of Oncology Therapies- Systematic Review and Best Practices Analysis

    Nov 1, 2012, 00:00

  • PRM7 Increasing Physical Activity in Patients With Chronic Disease- What is the Literature Telling Us?

    Nov 1, 2012, 00:00

  • PHS76 An Infuenza Vaccination Policy Based on a Previous Year's Illness

    Nov 1, 2012, 00:00

  • PCV58 The Cost Effectiveness of Amlodipine Valsartan and Hydrochlorothiazide Single Pill Combination in Turkey

    Nov 1, 2012, 00:00

  • PIN57 Economic Evaluation of 13-Valent Pneumococcal Vaccine in High Risk Pediatric Population, From the Public Payer Perspective in Brazil

    Nov 1, 2012, 00:00

  • PMD55 Sacral Nerve Modulation (SNM) for the Treatment of Idiopathic Refractory Overactive Bladder- Cost-Effective in the UK Compared to Optimal Medical Therapy, Botulinum Toxin a (BoNT-A) and Percutaneous Tibial Nerve Stimulation (PTNS)

    Nov 1, 2012, 00:00

  • PIH27 Cost Analysis of Neonatal and Pediatric Parenteral Nutrition in Belgium

    Nov 1, 2012, 00:00

  • UT3 Estimating Preference-Based Index from Cancer-Specific Quality of Life Measures for Use in Cost-Utility-Analysis

    Nov 1, 2012, 00:00

  • PMD45 Estimating Economic Impact of Angiogenesis-Specific Imaging in Metastatic Breast Cancer

    Nov 1, 2012, 00:00

  • PSS6 Cost-of-Illness of Chronic Lymphoedema Patients in Hamburg and Suburban Region

    Nov 1, 2012, 00:00

  • PIN12 The Analysis for Inpatients Cost and Medical Insurance Coverage of Pneumonia in China, 2009

    Nov 1, 2012, 00:00

  • PRM52 Minimum Run-Time Requirements to Reduce Monte Carlo Error in Stochastic Simulations

    Nov 1, 2012, 00:00

  • PSY19 Access to Care and Health Outcomes Among the Hemophilia A Population in Developing Countries- A Comparison Between Philippines and Colombia

    Nov 1, 2012, 00:00

  • PIN2 Assessing the Diagnostic Performance of Human Immunodeficiency Virus Type 1 (HIV-1) Tropism Testing Methods- A Systematic Review of Genotypic Sequencing of the Third Hypervariable (V3) Loop and Enhanced-Sensitivity Phenotypic Assay Tec ...

    Nov 1, 2012, 00:00

  • PRM11 Evidence for Validity of a National Patient-Reported Survey in Japan- The Japan National Health and Wellness Survey

    Nov 1, 2012, 00:00

  • PCN1 Use of the 5-HT3-RA Antiemetics in the Prevention and Treatment of Radiation Induced Nausea and Vomiting

    Nov 1, 2012, 00:00

  • PCN51 Comprehensive Investigation of Adverse Event (AE)-Related Costs in Patients With Metastatic Breast Cancer (mBC) Treated With First- and Second-Line Chemotherapies

    Nov 1, 2012, 00:00

  • PHP153 Supporting Payers with Collaborative HTA Tools in Making Evidence-Based Decisions- The United States Experience and International Needs in Europe and Globally

    Nov 1, 2012, 00:00

  • PHS24 Cost of Traffic Accidents Related to Low Visibility Conditions- A Cost of Illness Study

    Nov 1, 2012, 00:00

  • PRM87 Cross-Cultural Validation of the Huntington Quality of Life Instrument in Spain

    Nov 1, 2012, 00:00

  • PCN71 Cost-Effectiveness Analysis of Cetuximab and Panitumumab as First-Line Therapies for Metastatic Colorectal Cancer in Spain

    Nov 1, 2012, 00:00

  • PIN70 Cost-Effectiveness of an Individualized Approach in the Treatment of HBeAg-Negative CHB Patients With Peginterferon Alfa-2A in Italy

    Nov 1, 2012, 00:00

  • PCN26 Geographic Variation Associated with Colorectal Cancer Prevalence in the United States

    Nov 1, 2012, 00:00

  • PSY15 Impact of Chronic Immune-Mediated Inflammatory Diseases on Work Productivity- Literature Review

    Nov 1, 2012, 00:00

  • PRM2 Development and Validation of a Health Economic Model for Corticosteroid-Induced Osteoporosis in Postmenopausal Women With Rheumatoid Arthritis in Japan

    Nov 1, 2012, 00:00

  • PGI14 Knowledge, Attitude and Practices Towards Hepatitis-B Among General Population of Quetta, Pakistan

    Nov 1, 2012, 00:00

  • PMD21 Cost Comparison of Spinal Fusion Procedures With Grafton Mixed With Local Bone Compared to Iliac Crest Bone

    Nov 1, 2012, 00:00

  • PCV25 A Pharmacoeconomic Assessment of Recombinant Tissue Plasminogen Activator Therapy for Acute Ischemic Stroke in a Tertiary Hospital in China

    Nov 1, 2012, 00:00

  • PRM82 Verification of Proportional Hazards Assumption in Cost-Effectiveness Analysis (CEA)

    Nov 1, 2012, 00:00

  • PHS61 Patient Involvement in Treatment Decisions and Its Perceived Impact on Patient Outcomes in Systemic Lupus Erythematosus (SLE)- A Comparison of Physician and Patient Perspectives

    Nov 1, 2012, 00:00

  • PSY15 Effectiveness of Fresh Frozen Plasma and Its Cost-Effectiveness in Iranian Acute Organophosphate Poisoning Patients

    Nov 1, 2012, 00:00

  • PRM143 Cluster Analysis and Principal Component Analysis to Assess the Variability of Data in Cost Evaluations- Methods and Applications in Oncology

    Nov 1, 2012, 00:00

  • PIH35 Disability-Adjusted-Life-Years (DALYs) Loss in Postmenopausal Women with Osteoporosis

    Nov 1, 2012, 00:00

  • PSU31 The Association Between Degenerative Disk Disease and Outcomes Among Patients Undergoing Lumbar Fusion Surgery

    Nov 1, 2012, 00:00

  • PCV24 The Practical Assessment of Same-Day Discharge With Scheduled Trans-Radial Percutaneous Coronary Intervention

    Nov 1, 2012, 00:00

  • PDB21 Direct Medical Costs of Diabetes-Related Complications in India

    Nov 1, 2012, 00:00

  • PCN63 The Relative Value of Dasatinib Versus Imatinib as First-Line Treatment for Chronic Myeloid Leukemia

    Nov 1, 2012, 00:00

  • PCN27 Disclosing Complementary and Alternative Medicines (CAM) Use to the Health Care Providers-A Descriptive Study

    Nov 1, 2012, 00:00

  • PHP74 Submission of New Drug Reimbursement and Pricing Applications to National Health Insurance (NHI) of Taiwan, Meeting Outcomes of the Drug Benefit Committee

    Nov 1, 2012, 00:00

  • PMD43 Comparison of Actual Costs Versus DRG Revenue of Cervical Arthroplasty in Patients With Degenerative Disc Disease in Germany

    Nov 1, 2012, 00:00

  • PCN156 Value Based Pricing in the UK; Industry Stakeholders' Perspectives

    Nov 1, 2012, 00:00

  • PRM54 Correlating Cost Effectiveness Output With Patient Level Data Input via the IMS Core Diabetes Model (CDM)

    Nov 1, 2012, 00:00

  • PDB10 Clinical Survey to Assess Outcomes in Diabetes Patients Using Pen Needles of Different Lengths

    Nov 1, 2012, 00:00

  • PMD26 Cost Effectiveness of HIV Testing in Non-Traditional Settings – the Hints Study

    Nov 1, 2012, 00:00

  • PHP20 Real-World Utilization Pattern of Biologics in Rheumatoid Arthritis- A Population-Based Study

    Nov 1, 2012, 00:00

  • PMH30 Cost-Minimization-Analysis of Paliperidon Palmitate in the Treatment of Schizophrenia in Austria

    Nov 1, 2012, 00:00

  • PRM59 Methods for Discounting in Economic Evaluation; An Empirical Comparison of Preferences in Money and Quality of Life

    Nov 1, 2012, 00:00

  • PSS26 Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA)- An Integrated Approach of Outcomes Measurement in Nail Psoriasis

    Nov 1, 2012, 00:00

  • PIN42 Cost-Effectiveness-Analysis of the Combination- Therapy Telaprevir, Peg-IFNα2a and Ribavirin in Patients With Chronic Hepatitis-C in Austria

    Nov 1, 2012, 00:00

  • PGI25 Cost-Utility Analysis of Telaprevir in Combination With Peginterferon Alpha and Ribavirin in Previously Treated Patients With Chronic Hepatitis C

    Nov 1, 2012, 00:00

  • PMS76 Patient Access to Biologics in Rheumatoid Arthritis- The Views of Health Care Stakeholders in Portugal

    Nov 1, 2012, 00:00

  • PMS33 Cost-Efficacy Analysis of Biologic Drugs in Combination With DMARDs in Patients With Active Rheumatoid Arthritis and Inadequate Response to Traditional DMARDs in Portugal – A Simplified Approach

    Nov 1, 2012, 00:00

  • PRM129 Final Reports for Translation and Linguistic Validation of Clinical Outcome Assessments

    Nov 1, 2012, 00:00

  • PMS2 Improvements in Physical Function and Disability in Patients With Rheumatoid Arthritis After Treatment With NNC0109-0012 (Anti-IL-20 mAb) in a Phase 2A Trial

    Nov 1, 2012, 00:00

  • PRS5 Cost Analysis of Childhood Asthma in Iran- A Cost Evaluation Based on Referral Center Data for Asthma Allergies

    Nov 1, 2012, 00:00

  • CA1 Discordant Diagnoses in Sarcoma, GIST and Desmoide Tumour in Fran Results From the Network RREPS

    Nov 1, 2012, 00:00

  • PMH18 Treatment Patterns and Costs in Patients With Schizophrenia in Germany

    Nov 1, 2012, 00:00

  • PSU16 High Cost Patients for Cardiac Surgery and Hospital Quality in Turkey

    Nov 1, 2012, 00:00

  • PHP58 Data Disclosure an Ongoing Process Towards More Transparency

    Nov 1, 2012, 00:00

  • ISPOR 15th Annual European Congress Disclosure Information for Research Presentations

    Nov 1, 2012, 00:00

  • PHS64 Shared Decision Making in Secondary Care- Rheumatologic Patient's Perspective

    Nov 1, 2012, 00:00

  • PHP41 Risk Management in Iranian Pharmaceutical Companies to Ensure Accessibility and Quality of Medicines

    Nov 1, 2012, 00:00

  • PHP109 Evaluation of the Use of Sedation for Adults Using Mechanical Ventilators in a Hospital in Taiwan

    Nov 1, 2012, 00:00

  • PMD56 Cost-Efectiveness Analysis Comparing the Application or Not of Whole Brain Irradiation Before Stereotectic Radiosurgery for the Treatment of One to Four Brain Metastases, According to Brazilians Third-Party Private Payer's Perspective ...

    Nov 1, 2012, 00:00

  • PIN17 Cost-Utility Analysis of Pneumococcal Nontypeable Haemophilus Influenza Protein-D Conjugate Vaccine (PHiD-CV) in Hong Kong Using Transmission Dynamic Model

    Nov 1, 2012, 00:00

  • PDB29 Glycemic Control and Diabetes-Related Health Care Costs in Type 2 Diabetes. A Retrospective Analysis Based on Administrative and Clinical Data

    Nov 1, 2012, 00:00

  • PND57 A Measure of Carer Quality of Life in Parkinson's Disease (PDQ-Carer)- Development and Validation of a Summary Index Score

    Nov 1, 2012, 00:00

  • PRM165 Validating Health Economic Models- Developing a Methodological Approach

    Nov 1, 2012, 00:00

  • PHS69 Impact Assessment of Minnesota Model for Alcohol Rehabilitation in Hospitalized Patients

    Nov 1, 2012, 00:00

  • PHP88 Workplace-Based Smoking Cessation Programmes – Identifying the Gaps Between Evidence and Practice

    Nov 1, 2012, 00:00

  • PMD71 The Switch Study- The Impact of Continuous Glucose Monitoring on Health Care Resource Utilization

    Nov 1, 2012, 00:00

  • PRM41 Designing Patient Registries- A Case-Study Using an Online Interactive Data Analysis Tool

    Nov 1, 2012, 00:00

  • PGI38 The Consumption of Proton-Pump Inhibitors in Slovakia

    Nov 1, 2012, 00:00

  • DB3 Indirect Treatment Comparison (ITC) or Cost-Effectiveness Analysis (CEA)- a Study

    Nov 1, 2012, 00:00

  • PHS98 Clinical Characteristics, Treatment Patterns, and Resource Utilization in a Real-World European Population With Diverticulitis

    Nov 1, 2012, 00:00

  • PRM175 Identification and Translation of Culturally Bound Terms in Patient Reported Outcome Measures

    Nov 1, 2012, 00:00

  • PND24 Methodological Considerations in Cost of Illness Studies on Alzheimer Disease

    Nov 1, 2012, 00:00

  • PRM64 Bayesian MTC Models to Combine Evidence From Different Trial Designs

    Nov 1, 2012, 00:00

  • PIN45 Health Economic Impact of Infant Vaccination Program With PHiD-CV and PCV13 Using New Efficacy/Effectiveness Data. Example of Finland

    Nov 1, 2012, 00:00

  • PMS5 Benefit-Risk Analysis of Adalimumab and Alternative Treatments for Moderate-to-Severe Rheumatoid Arthritis

    Nov 1, 2012, 00:00

  • PHP37 New Classification of Traditional and Innovative Pharmaceutical Payment Methods

    Nov 1, 2012, 00:00

  • PUK14 Cost-Effectiveness Analysis of Mirabegron Versus Tolterodine Extended Release in the Treatment of Patients With Overactive Bladder in the United States

    Nov 1, 2012, 00:00

  • PCN112 Characteristics of Cancer Patients Who Seek Cytostatic Therapy in Korea- A Pilot Study

    Nov 1, 2012, 00:00

  • PSY18 Clinical Outcomes, Resource Utilization and Treatment Cost of Myelodysplastic Syndromes and Acute Myeloide Leukemia in a Real World Setting- Single-Center Experience

    Nov 1, 2012, 00:00

  • PCV112 Dosage Analysis of CHF Therapies on the Basis of Hungarian Claim Database

    Nov 1, 2012, 00:00

  • PHS85 The Cost of Public Cancer Prevention in Alberta

    Nov 1, 2012, 00:00

  • PCN2 Data Analyses on Prevalence and Treatment of Acute Myeloid Leukaemia in Germany

    Nov 1, 2012, 00:00

  • PIN59 Cost-Effectiveness of Amoxicillin Clavulanate Directed Towards the Application of Indicated at Primary Care in the Treatment of Community Acquired Pneumonia, Acute Rhinosinusitis, Tonsillopharyngitis, and Acute Otitis Media

    Nov 1, 2012, 00:00

  • PIN32 Economic Evaluation of Boceprevir for the Treatment of Patients With Genotype 1 Chronic Hepatitis C Virus Infection in Hungary

    Nov 1, 2012, 00:00

  • PMD58 Cost-Effectiveness Analysis of Leprosy Case Detection Methods in Northern Nigeria

    Nov 1, 2012, 00:00

  • PSU36 Evidence Based Medicine- A Case Study of its Application to Innovative Surgical Procedures in the UK

    Nov 1, 2012, 00:00

  • PIH7 Net Tax Revenue with a National Based Rotavirus Vaccination Program in Turkey

    Nov 1, 2012, 00:00

  • PGI40 Physician-Initiated Treatment Patterns of Ulcerative Colitis (UC) Patients in the UK- a Review of Chart-Abstracted Data

    Nov 1, 2012, 00:00

  • PRM170 Optimizing Public Health Decision Over Time- A Dynamic Budget Optimization Model With Multiple Criteria Decision Making

    Nov 1, 2012, 00:00

  • PIH2 Topical Estrogen Therapy in Postmenopausal Women - Indian Experience

    Nov 1, 2012, 00:00

  • PHP183 The Rocky Road to Market Equilibrium – Price Regulation and Entry Liberalization in Portuguese Retail Pharmacy

    Nov 1, 2012, 00:00

  • PRS3 Real World Effectiveness and Relative Effectiveness of Omalizumab. An Historic-Prospective Design Study

    Nov 1, 2012, 00:00

  • PMH26 Cost-Effectiveness of Atypical Versus Typical Antipsychotics in Patients With Schizophrenia in Russia

    Nov 1, 2012, 00:00

  • PSS20 Cost-Utility Analysis of Treatments for Macular Edema Secondary to Retinal Vein Occlusion

    Nov 1, 2012, 00:00

  • PSU7 Seasonal Periodicity of Secondary Hip Replacement After Femoral Neck Fractures With Reduction Internal Screw Fixation Aged Over 60

    Nov 1, 2012, 00:00

  • PCN21 Melody Brasil- Real World Health Outcomes of the Treatment of Metastatic Melanoma Patients in the Brazilian Health System

    Nov 1, 2012, 00:00

  • PRM81 Methods of Obtaining Evidence From Published Survival Data for Use in Decision Analytic Models

    Nov 1, 2012, 00:00

  • PHP39 Explaning Differences in EU5 Market Penetration Levels and Rates of Biosimilars- The Case of Epoetine, Granulocyte-Colony Stimulating Factor, and Growth Hormones

    Nov 1, 2012, 00:00

  • DB1 Epidemiology, Treatment and Economic Burden of Type 2 Diabetes Mellitus With Nephropathy Complications in China

    Nov 1, 2012, 00:00

  • PCV118 Fixed-Dose Combinations and Their Value to Payers

    Nov 1, 2012, 00:00

  • PCV26 Lifetime Cost-Effectiveness Analysis of Ticagrelor in Patients With Acute Coronary Syndromes Based on the Plato Trial- A Singapore Health Care Perspective

    Nov 1, 2012, 00:00

  • PND73 Multiple Sclerosis in Germany- Outpatient Health Care Patterns

    Nov 1, 2012, 00:00

  • PRM49 EQ-5D Versus Disease-Specific HR-QoL Instruments – No Contest?

    Nov 1, 2012, 00:00

  • PHP30 Using Nationwide Administrative Data to Evaluate Generic Drug Pricing and Physician Prescription

    Nov 1, 2012, 00:00

  • PND45 Differential Outcomes in Patients With Alzheimer'S Disease (AD) Treated With Donepezil 23

    Nov 1, 2012, 00:00

  • PIN7 Estimate of Infectious Disease Burden Attributable to Climate Change

    Nov 1, 2012, 00:00

  • PDB14 Prevalence of Hypertension and/or Obesity in Patients With Type 2 Diabetes Mellitus in Asia- A Systematic Literature Review

    Nov 1, 2012, 00:00

  • PMD32 Outcomes and Costs of Isolated Aortic Valve Replacements Associated With the Mini-Invasive Implantation of a New Sutureless and Collapsed Valve in Italy, France, Germany, and UK

    Nov 1, 2012, 00:00

  • PHP26 Consumption of Antidiabetics in Serbia in 2010- A Comparison with Croatia and Denmark

    Nov 1, 2012, 00:00

  • MA4 Adequate Adherence to Intranasal Corticosteroids is Associated With Significantly Reduced Number and Costs of Outpatient Visits Among Patients Newly Diagnosed With Allergic Rhinitis

    Nov 1, 2012, 00:00

  • PIH24 Economic Evaluation of Ulipristal Acetate Tablets for the Treatment of Patients with Moderate and Severe Symptoms of Uterine Fibroids

    Nov 1, 2012, 00:00

  • PRM4 Assessment of Immunosuppressive Therapies for Renal Transplantation - Criteria Considered for Evaluation by the EMA, European HTA Agencies and the German IQWiG

    Nov 1, 2012, 00:00

  • PHS28 The Cost of Management of Patients With Atrial Fibrillation - An Observational Study in UK NHS Primary Care

    Nov 1, 2012, 00:00

  • PHP27 Implementation of the Transparency Directive in Hungary- Special Focus on Time Limits for Pricing and Reimbursement Decisions

    Nov 1, 2012, 00:00

  • PIN68 Cost-Minimization Analysis of Caspofungin Versus Liposomal Amphotericin B for the Treatment of Febrile, Neutropenic Patients With a Presumed Fungal Infection in the Netherlands

    Nov 1, 2012, 00:00

  • PIH12 Burden of Early-Onset Neonatal Sepsis in the Russian Federation

    Nov 1, 2012, 00:00

  • PGI6 Adherence to 5-Aminosalicylic Acid (5-ASA) Therapy for Ulcerative Colitis (UC)- Impact on Health Care Costs

    Nov 1, 2012, 00:00

  • PSS15 A New Insight Into Cost-Effectiveness Analyses in Atopic Dermatitis- The Tacrolimus 0.1% Ointment Versus Ciclosporin Comparison

    Nov 1, 2012, 00:00

  • PMH46 Determinants of Health-Related Quality of Life in Japanese Patients With Chronic Schizophrenia

    Nov 1, 2012, 00:00

  • RE2 A Detailed Comparison of Dutch and Swedish Drug Reimbursement Decisions- What Evidence is Available, Which Criteria are Used, and is the Decision-Making Process Transparent?

    Nov 1, 2012, 00:00

  • CN3 Cost-Effectivessness Analysis of Treatments in Adult Cancer Patients With Low Risk Febrile Neutropenia in Thailand

    Nov 1, 2012, 00:00

  • PIH10 Cost Effectiveness Comparison Between Dienogest and Gonadotropin-Releasing Hormone Analogs in Turkey

    Nov 1, 2012, 00:00

  • PHP17 Consumption Patterns, Traditional Market and Regulation in the Pharmaceutical Industry. Evidence for Two Therapeutic Groups in Insured Population

    Nov 1, 2012, 00:00

  • PGI15 Cost-Effectiveness Analysis of Lactest, a New Diagnostic Drug Test for Hypolactasia in Spain

    Nov 1, 2012, 00:00

  • PIN47 Cost-Effectiveness Analysis of the Primovaccination of Newborns Against Tuberculosis in Slovakia

    Nov 1, 2012, 00:00

  • PIN3 Evaluation of the Relationship Between Vancomycin Trough Concentration and Clinical Outcome in Hospitalized Patients With Orsa Bacteremia and the Relationship Between Vancomycin Trough Concentration and Nephrotoxicity

    Nov 1, 2012, 00:00

  • PHS36 Cost Drivers of Household Treatment of Presumptive Malaria in Home-Based Management of Malaria in Ejisu-Juaben Municipality

    Nov 1, 2012, 00:00

  • PCN20 Inhaled Corticosteroid Use and Risks of Lung Cancer and Laryngeal Cancer

    Nov 1, 2012, 00:00

  • ISPOR 5TH Asia-Pacific Conference Research Abstracts Author Index

    Nov 1, 2012, 00:00

  • PMH3 Intravenous Droperidol and Olanzapine as Adjuncts to Midazolam for the Acutely Agitated Patient- A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Clinical Trial

    Nov 1, 2012, 00:00

  • PSU30 Effects of Different Clinical Practices of Laparoscopic Surgery for Endometriosis Treatment on Cost of Therapy

    Nov 1, 2012, 00:00

  • PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases

    Nov 1, 2012, 00:00
  • «
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128 (current)
  • 129
  • 130
  • »